BioMerieux COVID testing product gets U.S. emergency use authorization

Biomérieux, a French healthcare company specialising in diagnostics, said on Monday it had won more positive feedback from the U.S. Food & Drug Administration (FDA) regulator for its product aimed at helping test for the coronavirus.